Key facts
- GeneDx Holdings is subject to a securities class action lawsuit.
- The lawsuit was filed after a 49% drop in the company's stock price.
- The stock price drop followed the company's Q1 2026 earnings report.
- The lawsuit is related to the company's acquisition of Fabric Genomics.
GeneDx Holdings (NASDAQ: WGS) is facing a securities class action lawsuit. The lawsuit was initiated after the company's stock price plummeted by $33.42, representing a 49% decrease, on May 5, 2026. This significant drop occurred in response to the company's Q1 2026 earnings report, which highlighted issues potentially stemming from its acquisition of Fabric Genomics. The lawsuit seeks to represent investors who were impacted by these events.